Related Experiment Video
Updated: Jun 26, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Autophagy in cancer and chemotherapy
Shida Yousefi1, Hans-Uwe Simon
1Institute of Pharmacology, University of Bern, Friedb0ihlstrasse 49, CH-3010 Bern, Switzerland.
Abstract:
Cancer cells often exhibit mutations in critical molecules of the apoptotic machinery, resulting in resistance to common anticancer therapies. In the absence of apoptosis, autophagic cell death can be an alternative form of cell death by excessive self-digestion. Therefore, autophagic cell death can be considered as a backup cell death mechanism when apoptotic cell death mechanisms fail. However, many tumors also exhibit deficiencies in autophagy that may result in both genomic instability and further anticancer drug resistance. This chapter summarizes our current understanding regarding the regulation of autophagy in tumors and discusses potential new anticancer drug treatment strategies.
Insights
Cancer cells resistant to apoptosis can die via autophagy, a backup cell death pathway. However, impaired autophagy in tumors can worsen drug resistance and genomic instability, necessitating new treatment strategies.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cancer cells frequently develop mutations in apoptotic pathways, leading to resistance against conventional therapies.
- Autophagic cell death presents an alternative cell death mechanism when apoptosis is compromised.
- Tumor cells can also exhibit autophagy deficiencies, contributing to genomic instability and enhanced drug resistance.
Purpose of the Study:
- To summarize the current understanding of autophagy regulation in tumors.
- To explore novel anticancer drug treatment strategies targeting autophagy.
Main Methods:
- Literature review and synthesis of current research on cancer cell death mechanisms.
- Analysis of the role of autophagy in tumor progression and therapeutic resistance.
Main Results:
- Apoptosis resistance is a hallmark of many cancers, making alternative cell death pathways like autophagy crucial.
- Deficiencies in autophagy are observed in numerous tumors, exacerbating genomic instability and drug resistance.
- Targeting autophagy presents a promising avenue for developing new anticancer therapies.
Conclusions:
- Autophagy serves as a critical backup cell death mechanism in cancer, particularly when apoptosis fails.
- Understanding and manipulating autophagy in tumors is essential for overcoming therapeutic resistance and improving patient outcomes.
- Further research into autophagy modulation holds significant potential for innovative cancer treatment strategies.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules

